Balchem Corporation

NasdaqGS:BCPC Lagerbericht

Marktkapitalisierung: US$4.7b

Balchem Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Für Balchem wird ein Gewinn- und Umsatzwachstum von 12.2% bzw. 6.6% pro Jahr prognostiziert, während der Gewinn je Aktie voraussichtlich um 11% pro Jahr steigen soll.

Wichtige Informationen

12.2%

Wachstumsrate der Gewinne

11.02%

EPS-Wachstumsrate

Chemicals Gewinnwachstum21.5%
Wachstumsrate der Einnahmen6.6%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert04 Aug 2025

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Jul 31
Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Recent updates

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Balchem Corporation: The Next Earnings Release Should Guide Investors

Jul 14

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 17
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Mar 21
We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing

Mar 07
Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Jan 30
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Dec 06
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors

Nov 22
Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Oct 21
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Oct 07
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) Using Too Much Debt?

Sep 09
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today

Aug 27
Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today

Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon

Aug 13
Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Jul 31
Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Jun 29
Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable

Jun 15
Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable

Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Jun 10
Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

May 26
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Balchem: A Tale Of Two Businesses

May 10

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Mar 21
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Mar 05
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Balchem: Potential Turnaround Is In The Price

Feb 21

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Jan 03
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Dec 19
Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Nov 20
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Oct 19
Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Sep 09
The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 22
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Jul 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

May 28
Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 12
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Mar 14
We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Jan 11
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Dec 29
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 13
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Nov 29
Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Sep 20
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Acquisitions And Cost Pressures Draw Attention

Sep 12

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:BCPC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,0891712022453
12/31/20251,0251521682003
6/30/2025986143153187N/A
3/31/2025965137151185N/A
12/31/2024954128146182N/A
9/30/2024942122162197N/A
6/30/2024932117159192N/A
3/31/2024930115147182N/A
12/31/2023922109146184N/A
9/30/2023926103118158N/A
6/30/202394199106153N/A
3/31/202394699117166N/A
12/31/202294210589139N/A
9/30/202292310991141N/A
6/30/202287710995139N/A
3/31/202284210286127N/A
12/31/202179996123161N/A
9/30/202176793128164N/A
6/30/202174490125160N/A
3/31/202171588134169N/A
12/31/202070485117150N/A
9/30/202068983108136N/A
6/30/202067382116143N/A
3/31/20206618199125N/A
12/31/20196448096124N/A
9/30/201964180103131N/A
6/30/20196377894121N/A
3/31/201963978N/A116N/A
12/31/201864479N/A119N/A
9/30/2018639100N/A110N/A
6/30/201863597N/A112N/A
3/31/201861894N/A113N/A
12/31/201759590N/A111N/A
9/30/201757664N/A107N/A
6/30/201756462N/A97N/A
3/31/201755660N/A101N/A
12/31/201655356N/A108N/A
9/30/201654556N/A105N/A
6/30/201654756N/A110N/A
3/31/201654356N/A107N/A
12/31/201555260N/A104N/A
9/30/201558263N/A115N/A
6/30/201560364N/A108N/A
3/31/201560059N/A102N/A
12/31/201454153N/A85N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BCPCDas prognostizierte Gewinnwachstum (12.2% pro Jahr) liegt über der Sparquote (3.1%).

Ertrag vs. Markt: BCPCDie Erträge des Unternehmens (12.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).

Hohe Wachstumserträge: BCPCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: BCPCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9.8% pro Jahr).

Hohe Wachstumseinnahmen: BCPCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von BCPC in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2025/10/05 10:17
Aktienkurs zum Tagesende2025/10/03 00:00
Gewinne2025/06/30
Jährliche Einnahmen2024/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Balchem Corporation wird von 9 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.